Headaches following a meningococcal vaccine are not common, but trying to figure out to whom and when some of these vaccines should be given can easily bring one on in any practitioner. As prophylaxis against headaches, here’s a rundown on the available vaccines, at-a-glance:
|Menomune||Polysacch||A, C, W, Y||1981||
|Menactra||Conjugate||A, C, W, Y||2005||
9 mo - 55 ya
|Menveo||Conjugate||A, C, W, Y||2010||2 mo - 55 ya|
|MenHibrix||Conjugate||C, Y, Hib||2012||6 w -18 mo|
|Trumenba||Protein||B||2014||10 - 25yb
10 - 25yb
Now let’s get more specific about the two new kids on the block, Trumemba and Bexsero.
1. For which of the following groups is routine meningococcal B (MenB) vaccination not recommended?
A. Individuals with severe combined immunodeficiency disease (SCID)
B. All persons over the age of 10 with functional or anatomic asplenia
C. All persons over the age of 10 with persistent complement component deficiency
D. None of the above; that is, all the above groups should be routinely vaccinated
For answer, discussion, and next question, please click here.
Table acquired from http://www.immunize.org/askexperts/experts_men.asp on November 5, 2015. We thank the Immunization Action Coalition.
Immunization Action Coalition. Ask the Experts: Diseases & Vaccines. Meningococcal Vaccines.